附上FDA指南Nasal Spray and Inhalation Solution, Suspension,and Spray Drug Products — Chemistry,Manufacturing, and Controls Documentation,
“All aqueous-based oral inhalation drug products must be manufactured as sterile products (21 CFR 200.51), and their sterility should be ensured through the expiration dating period.”
应当按照无菌制剂要求生产